Navigene Genetic Science Pvt Ltd: Company Profile

Background

Company Overview

Navigene Genetic Science Pvt Ltd, established in 2012, specializes in genetic diagnostics and research, focusing on non-invasive preventive testing for newborns, children, and adults. The company is headquartered in Thane, Maharashtra, India. Navigene's mission is to enable early and accurate prediction and diagnosis of disorders through cutting-edge genetic screening solutions. Its flagship product, Navigene Baby Screen, screens newborns for 110 genetic and metabolic disorders as early as the third day of life using a simple urine sample collected on special filter paper. This approach is among the most comprehensive screening tests globally.

Mission and Vision

Navigene is committed to safeguarding patients' health today to ensure they can thrive tomorrow. The company strives to provide robust, affordable, and scalable genetic screening solutions tailored to the needs of hospitals, laboratories, institutions, and regions.

Industry Significance

Navigene plays a pivotal role in the field of genetic diagnostics by offering non-invasive screening methods that facilitate early detection and management of genetic disorders. Its innovative approach addresses a critical need in preventive healthcare, particularly in India, where the incidence of genetic disorders is significant.

Key Strategic Focus

Core Objectives

• Early Detection and Prevention: Implementing non-invasive genetic screening to identify disorders at the earliest possible stage.

• Affordability and Scalability: Providing cost-effective solutions that can be widely adopted across diverse healthcare settings.

• Customization: Tailoring services to meet the specific needs of various healthcare providers and regions.

Areas of Specialization

• Newborn Screening: Offering comprehensive screening for genetic and metabolic disorders in newborns.

• Metabolic Fingerprinting: Assessing metabolic profiles to identify potential health risks.

• Prenatal Screening: Providing genetic testing for expectant mothers to assess fetal health.

• Cytogenetic and Molecular Diagnostics: Conducting detailed genetic analyses to diagnose various conditions.

Key Technologies Utilized

• Non-Invasive Screening Methods: Utilizing urine samples collected on filter paper for newborn screening.

• Advanced Diagnostic Equipment: Employing state-of-the-art technologies from leading global institutions.

• Proprietary Algorithms: Developing unique algorithms for analyzing genetic data.

Primary Markets Targeted

• Hospitals and Birthing Centers: Collaborating with healthcare facilities to implement screening programs.

• Pediatric Clinics and IVF Centers: Partnering with specialized clinics for genetic diagnostics.

• International Markets: Expanding services to Southeast Asia through joint ventures and partnerships.

Financials and Funding

Funding History

In November 2012, Navigene received an undisclosed investment from IncuCapital, an early-stage venture capital firm. This funding aimed to support the company's expansion and development of its genetic screening services.

Utilization of Capital

The capital raised has been utilized for:

• Infrastructure Development: Establishing and upgrading laboratory facilities.

• Technology Enhancement: Implementing advanced diagnostic equipment and proprietary algorithms.

• Market Expansion: Extending services to new regions and international markets.

Pipeline Development

Key Pipeline Candidates

• Navigene Baby Screen: A non-invasive screening test for 110 genetic and metabolic disorders in newborns.

• Metabolic Fingerprinting Services: Assessing metabolic profiles in children and adults to identify health risks.

• Prenatal Screening Programs: Genetic testing services for expectant mothers to assess fetal health.

Stages of Development

• Navigene Baby Screen: Fully developed and operational, with services offered across multiple cities in India.

• Metabolic Fingerprinting and Prenatal Screening: Services are in the implementation phase, with plans for broader rollout.

Target Conditions

• Navigene Baby Screen: 110 genetic and metabolic disorders in newborns.

• Metabolic Fingerprinting: Various metabolic disorders in children and adults.

• Prenatal Screening: Genetic conditions affecting fetal development.

Anticipated Milestones

• Expansion of Service Reach: Increasing the number of hospitals and clinics offering Navigene's services.

• International Expansion: Establishing a fully functional facility in Southeast Asia.

Technological Platform and Innovation

Proprietary Technologies

• Filter Paper-Based Collection: A non-invasive method for collecting urine samples for newborn screening.

• Proprietary Algorithms: Unique algorithms developed for analyzing genetic data.

Significant Scientific Methods

• Metabolic Fingerprinting: Assessing metabolic profiles to identify potential health risks.

• Genetic Screening: Comprehensive testing for a wide range of genetic and metabolic disorders.

Leadership Team

Dr. Rishi Dixit – Co-Founder, Managing Director & CEO

Dr. Dixit is a thought leader in healthcare with over 14 years of expertise in preventive screening and diagnostics, focusing on the early detection of genetic disorders. He has partnered with state governments across India to drive large-scale screening initiatives for hemoglobinopathies, especially in rural and tribal regions. An MBBS graduate with an MBA from Sydenham College, Mumbai, Dr. Dixit blends medical expertise with business leadership to shape Navigene’s mission of advancing preventive diagnostics.

Surojit Nandy – Co-Founder, Director & COO

Surojit Nandy is a seasoned entrepreneur with over two decades of experience in founding and scaling startups across diverse sectors, including healthcare, finance, real estate, and human resources. He co-founded Navigene alongside Dr. Dixit and has been deeply involved in various facets of the company's operations, culminating in his appointment as full-time Chief Operating Officer and Director in 2024. Surojit holds a Chemistry (Hons.) degree from the University of Calcutta and an MBA from Symbiosis Institute, Pune.

Dr. Dipanjana Datta – Consultant Geneticist & Senior Genetic Counsellor

Dr. Datta is a molecular geneticist with a PhD in Human Genetics from the Indian Institute of Chemical Biology. She leads in prenatal and reproductive genetics, rare disease diagnostics, nephrogenetics, and neuromuscular disorders. Dr. Datta has participated in the Indian Genome Variation Consortium and holds a patent for a biomarker-based diagnostic approach in head and neck cancer.

Lakshita Chauhan – Head - Genomics, Geneticist & Genetic Counsellor

Lakshita Chauhan is one of India’s foremost genetic counselors, widely recognized for her contributions to medical genetics. She established the inaugural genetics clinic and laboratory with a clinical geneticist in New Delhi and has a distinguished career spanning various counseling domains. Lakshita was awarded the National Youth Icon Award in Genetic at the 3rd National Symposium on genetic diseases held in New Delhi.

Anirvan Dam – Director, Sales-Retail

Anirvan Dam serves as the Director of Sales – Retail at Navigene, where he spearheads both retail and institutional sales initiatives. He holds a Post Graduate Diploma in Business Management with a specialization in Marketing and is an alumnus of the National Institute of Sales. Anirvan has a robust career spanning corporate and retail sales across diverse sectors and is the founder of The Kids Clinic, a pediatric healthcare venture.

Competitor Profile

Market Insights and Dynamics

The genetic diagnostics market is experiencing significant growth, driven by increasing awareness of genetic disorders and advancements in diagnostic technologies. The demand for non-invasive screening methods, such as those offered by Navigene, is rising, particularly in regions with high birth rates and a prevalence of genetic conditions.

Competitor Analysis

• Mapmygenome: Offers personalized health solutions based on genetic tests, providing actionable steps for individuals and their physicians towards a healthier life.

• MedGenome Labs: Provides clinical genomics solutions for personalized healthcare, with a focus on oncology, pediatrics, prenatal, cardiology, ophthalmology, and neurology.

• Positive Bio Sciences